<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02130271</url>
  </required_header>
  <id_info>
    <org_study_id>2013P-002174</org_study_id>
    <nct_id>NCT02130271</nct_id>
  </id_info>
  <brief_title>PET/MRI Imaging of Neuraxial Inflammation in Sciatica Patients</brief_title>
  <official_title>PET/MRI Imaging of Neuraxial Inflammation in Sciatica Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see if the spine shows areas of inflammation using a specific&#xD;
      type of imaging (pictures).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine if inflammation around the spinal nerves can be&#xD;
      identified using a radioactive tracer [11C] PBR28 and integrated PET/MRI scan for the purpose&#xD;
      of better treating patients who have radicular lumbar pain with epidural steroid injections.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2014</start_date>
  <completion_date type="Actual">December 2018</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Inflammation in the spine</measure>
    <time_frame>2 hours</time_frame>
    <description>The presence of inflammation in the spine using the radioactive tracer [11C]PBR28.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Scores on the Visual Analog Scale (VAS)</measure>
    <time_frame>up to 3 months</time_frame>
    <description>The subject's pain score (VAS) at baseline and up to 3 months after the ESI treatment.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Sciatica</condition>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>Healthy subjects with no pain.&#xD;
Radioactive dye&#xD;
PET/MRI&#xD;
Blood draw</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sciatica</arm_group_label>
    <description>Subjects with sciatica and scheduled for an epidural steroid injection (ESI).&#xD;
Radioactive dye&#xD;
PET/MRI&#xD;
Blood draw</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Radioactive dye</intervention_name>
    <description>The radioactive dye [11C]PBR28 will be administered through an intravenous line (IV).</description>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Sciatica</arm_group_label>
    <other_name>[11C]PBR28</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>PET/MRI</intervention_name>
    <description>All subjects will undergo a simultaneous PET/MRI scan. The scan will be up to 2 hours long.</description>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Sciatica</arm_group_label>
    <other_name>Integrated MR-PET 3 Tesla scanner (Siemens Biograph mMR).</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood draw</intervention_name>
    <description>Up to 11 tablespoons of blood will be drawn through an intravenous line (IV-line) for two purposes: 1) testing for the subject's genetic affinity to the radioactive dye, and 2) testing for the presence inflammatory biomarkers.</description>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Sciatica</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      A blood sample will be taken from healthy subjects only at Visit 1. The blood sample will&#xD;
      genotyped. Genotyping will identify if the subject makes proteins that will bind the&#xD;
      radioactive tracer.&#xD;
&#xD;
      A blood sample will be drawn for Genotyping at Visit 2 from all subjects.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        1. Subject is currently diagnosed with lower extremity radicular/sciatica pain.&#xD;
&#xD;
          2. Healthy subjects with no pain from the local community.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria for pain subjects:&#xD;
&#xD;
          1. Subject is 18-75 years old.&#xD;
&#xD;
          2. Subject is able to give written informed consent.&#xD;
&#xD;
          3. Subject is currently diagnosed with lower extremity radicular pain regardless of&#xD;
             specific or suspected etiologies.&#xD;
&#xD;
          4. Subject has a clear dermatomal distribution of the painful area extending to the&#xD;
             distal lower extremities.&#xD;
&#xD;
          5. Subject reports ongoing pain intensity of 4 or greater using the visual analogue scale&#xD;
             (VAS) during the week prior to enrollment.&#xD;
&#xD;
        Inclusion criteria for healthy subjects:&#xD;
&#xD;
          1. Subject is 18-75 years old.&#xD;
&#xD;
          2. Subject is able to give written informed consent.&#xD;
&#xD;
          3. Subject has no history of chronic back/spine pain.&#xD;
&#xD;
        Exclusion criteria for all groups:&#xD;
&#xD;
          1. Subject recently received a lumbar ESI (within 8 weeks).&#xD;
&#xD;
          2. Subject starts new NSAID medication for pain during the study.&#xD;
&#xD;
          3. Subject has predominantly axial low back pain.&#xD;
&#xD;
          4. Subject has known pain condition secondary to hip joint arthritis.&#xD;
&#xD;
          5. Subject is pregnant or breastfeeding.&#xD;
&#xD;
          6. Subject has allergy to lidocaine.&#xD;
&#xD;
          7. Subject is treated with chronic corticosteroid therapy.&#xD;
&#xD;
          8. Subject is on anticoagulation therapy (i.e. Coumadin, Plavix, or Lovenox).&#xD;
&#xD;
          9. Subject has a known bleeding disorder (i.e. hemophilia).&#xD;
&#xD;
         10. Subject has uncontrolled high blood pressure [&gt;170/100].&#xD;
&#xD;
         11. Subject has a known heart condition.&#xD;
&#xD;
         12. Subject has known inflammatory disease (i.e. inflammatory bowel disease; ankylosing&#xD;
             spondylitis; etc.).&#xD;
&#xD;
         13. Subject has known liver dysfunction or renal insufficiency or impaired elimination&#xD;
             (Renal dysfunction is defined as eGFR &lt; 60. Hepatic dysfunction is defined as LFTs â‰¥&#xD;
             3x ULN).&#xD;
&#xD;
         14. Subject has been hospitalized recently (within one month) for a major psychiatric&#xD;
             disorder (i.e. major depression, bipolar disorder, schizophrenia, anxiety disorder, or&#xD;
             psychosis).&#xD;
&#xD;
         15. Subject has contraindications to MRI and PET scanning (i.e. presence of a cardiac&#xD;
             pacemaker or pacemaker wires, metallic particles in the body, vascular clips in the&#xD;
             head or previous neurosurgery, prosthetic heart valves, or claustrophobia).&#xD;
&#xD;
         16. Subject had research-related radiation exposure in the last 12 months.&#xD;
&#xD;
         17. Subject tests positive for use of illicit drugs, marijuana, or non-prescribed drugs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi Zhang, MD, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MGH Center for Translational Pain Research</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.massgeneral.org/translationalpainresearch/</url>
    <description>MGH Center for Translational Pain Research</description>
  </link>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>April 24, 2014</study_first_submitted>
  <study_first_submitted_qc>May 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2014</study_first_posted>
  <last_update_submitted>September 13, 2019</last_update_submitted>
  <last_update_submitted_qc>September 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Yi Zhang, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Sciatica</keyword>
  <keyword>PET scan</keyword>
  <keyword>MRI</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Epidural Steroid Injection (ESI)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sciatica</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

